Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Non Operating Income (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Non Operating Income for 10 consecutive years, with -$433162.0 as the latest value for Q4 2022.

  • Quarterly Non Operating Income rose 33.09% to -$433162.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$1.7 million through Dec 2022, up 67.45% year-over-year, with the annual reading at -$248560.0 for FY2025, 23.37% up from the prior year.
  • Non Operating Income hit -$433162.0 in Q4 2022 for Kraig Biocraft Laboratories, down from -$285076.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$35664.0 in Q2 2018 to a low of -$2.3 million in Q3 2021.
  • Historically, Non Operating Income has averaged -$494704.5 across 4 years, with a median of -$275651.0 in 2021.
  • Biggest five-year swings in Non Operating Income: crashed 88.58% in 2019 and later soared 87.68% in 2022.
  • Year by year, Non Operating Income stood at -$61962.0 in 2018, then dropped by 15.61% to -$71636.0 in 2019, then crashed by 803.72% to -$647390.0 in 2021, then surged by 33.09% to -$433162.0 in 2022.
  • Business Quant data shows Non Operating Income for KBLB at -$433162.0 in Q4 2022, -$285076.0 in Q3 2022, and -$501465.0 in Q2 2022.